Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer: A phase II trial

Purpose: To analyze the safety and efficacy of orally administered metronomic capecitabine plus pyrotinib in HER2 positive metastatic breast cancer (MBC) patients, we conducted a prospective phase II study with a single-arm design. Methods: HER2 positive patients received oral metronomic capecitabin...

Descripció completa

Dades bibliogràfiques

Autors principals:	Maiyue He, Jiaxuan Liu, Zijing Wang, Fei Ma, Jiayu Wang, Pin Zhang, Qing Li, Peng Yuan, Yang Luo, Ying Fan, Hongnan Mo, Bo Lan, Qiao Li, Binghe Xu
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2023-12-01
Col·lecció:	Breast
Matèries:	Phase II study Metastatic breast cancer HER2-Positive pyrotinib capecitabine metronomic chemotherapy
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S096097762300557X
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!